Scientists are intensely interested in a blood protein called p-tau217 because it's a promising marker for Alzheimer's disease in older adults. But what about in younger people? A small study of 41 adolescents looked to see if this protein changes during the teenage years or is affected by common conditions like psychiatric or metabolic issues. They found no link—p-tau217 levels didn't correlate with age, body mass index, or the presence of those health conditions in this group.
However, the study uncovered a major practical hurdle. When researchers compared two common ways of drawing blood—from a vein versus a newer, finger-prick device called Tasso+—the results were starkly different. The protein concentration was more than ten times higher in the samples from the finger-prick method. This means you absolutely cannot compare or mix results from these two collection techniques.
This research, involving teens with an average age of 16, is purely observational and very early. It tells us that in adolescents, this particular protein marker appears stable, but it raises a big red flag about how we measure it. The main takeaway isn't about Alzheimer's risk in teens; it's a crucial note for scientists: before we can use this test widely, we need to standardize how the blood is collected.
